TapImmune to Present at The MicroCap Conference

(Accesswire — March 28, 2018) – TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced that CEO Peter Hoang will present at The MicroCap Conference, to be held April 9-10, 2018, at The Essex House in New York City.

The MicroCap Conference

TapImmune Presentation

Date: Monday, April 9, 2018

Time: 9 a.m. (Eastern Time)

Location: The Essex House, Track 1

An audio webcast will be accessible via the News and Events section of the TapImmune website: https://www.markertherapeutics.com/events. An archive of the audio will remain available for 90 days following the presentation.[/vc_column_text][vc_empty_space height=”4px”][vc_column_text][pr-disclaimer]